- Home
- NSPR vs TNYA Comparison
NSPR vs TNYA Comparison
Compare NSPR & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- TNYA
- Stock Information
- Founded
- NSPR 2005
- TNYA 2016
- Country
- NSPR United States
- TNYA United States
- Employees
- NSPR N/A
- TNYA N/A
- Industry
- NSPR Medical/Dental Instruments
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- NSPR Health Care
- TNYA Health Care
- Exchange
- NSPR Nasdaq
- TNYA Nasdaq
- Market Cap
- NSPR 75.1M
- TNYA 73.8M
- IPO Year
- NSPR N/A
- TNYA 2021
- Fundamental
- Price
- NSPR $2.44
- TNYA $0.58
- Analyst Decision
- NSPR Strong Buy
- TNYA Strong Buy
- Analyst Count
- NSPR 2
- TNYA 5
- Target Price
- NSPR $4.50
- TNYA $8.60
- AVG Volume (30 Days)
- NSPR 44.5K
- TNYA 2.4M
- Earning Date
- NSPR 08-05-2025
- TNYA 08-07-2025
- Dividend Yield
- NSPR N/A
- TNYA N/A
- EPS Growth
- NSPR N/A
- TNYA N/A
- EPS
- NSPR N/A
- TNYA N/A
- Revenue
- NSPR $7,027,000.00
- TNYA N/A
- Revenue This Year
- NSPR $27.41
- TNYA N/A
- Revenue Next Year
- NSPR $127.08
- TNYA N/A
- P/E Ratio
- NSPR N/A
- TNYA N/A
- Revenue Growth
- NSPR 8.49
- TNYA N/A
- 52 Week Low
- NSPR $2.07
- TNYA $0.36
- 52 Week High
- NSPR $3.80
- TNYA $4.06
- Technical
- Relative Strength Index (RSI)
- NSPR 50.84
- TNYA 53.16
- Support Level
- NSPR $2.40
- TNYA $0.56
- Resistance Level
- NSPR $2.59
- TNYA $0.64
- Average True Range (ATR)
- NSPR 0.11
- TNYA 0.06
- MACD
- NSPR 0.00
- TNYA -0.00
- Stochastic Oscillator
- NSPR 57.50
- TNYA 41.37
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.